1. Immunogenic Cell Death Enhances Immunotherapy of Diffuse Intrinsic Pontine Glioma: From Preclinical to Clinical Studies
   Guohao Liu et al, 2022, Pharmaceutics CrossRef
2. STAT3 phosphorylation inhibitor Bt354 exhibits anti‐neoplastic activity in glioblastoma multiforme cells
   Yi‐Chun Chiang et al, 2024, Environmental Toxicology CrossRef
3. STAT3-EMT axis in tumors: Modulation of cancer metastasis, stemness and therapy response
   Mehrdokht Sadrkhanloo et al, 2022, Pharmacological Research CrossRef
4. Therapeutic Targets in Diffuse Midline Gliomas—An Emerging Landscape
   Elisha Hayden et al, 2021, Cancers CrossRef
5. Pediatric Diffuse Midline Gliomas: An Unfinished Puzzle
   Valentina Di Ruscio et al, 2022, Diagnostics CrossRef
6. Engineered extracellular vesicles (EVs): Promising diagnostic/therapeutic tools for pediatric high-grade glioma
   Yuan Lyu et al, 2023, Biomedicine & Pharmacotherapy CrossRef
7. Advanced Pediatric Diffuse Pontine Glioma Murine Models Pave the Way towards Precision Medicine
   Zirong Chen et al, 2021, Cancers CrossRef
8. Targeting Glioma Cells with Nutraceuticals: Therapeutic Effects Based on Molecular Mechanisms, New Evidence and Perspectives
   Marziyeh Salami et al, 2023, Mini-Reviews in Medicinal Chemistry CrossRef
9. Impact of phospholipase C β1 in glioblastoma: a study on the main mechanisms of tumor aggressiveness
   Stefano Ratti et al, 2022, Cellular and Molecular Life Sciences CrossRef
10. STAT3 is a biologically relevant therapeutic target in H3K27M-mutant diffuse midline glioma
    Liang Zhang et al, 2022, Neuro-Oncology CrossRef
11. Radiotherapy and radio‐sensitization in H3K27M‐mutated diffuse midline gliomas
    Chao Liu et al, 2023, CNS Neuroscience & Therapeutics CrossRef